SCHEMBL3203452

SCHEMBL3203452

CC(C)(C)OC(=O)c1cccc(N(Cc2ccccc2F)c2ccc(OC(F)F)c(OC(F)F)c2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.37
PDE4D Q08499 3/20 0.37
PDE4B Q07343 2/20 0.37
PDE4C Q08493 2/20 0.37
SLC7A5 Q01650 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RIPK1 Q13546 1/20 0.34
POLB P06746 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
RECQL P46063 1/20 0.33
PTPN1 P18031 1/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3194246 0.90 SLC7A5 (0.38) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL3129590 0.86 PDE4A (0.43) PDE4APDE4DPDE4BPDE4CPOLB
SCHEMBL3212697 0.86 POLB (0.36) SLC7A5KDM4EPOLBMEN1KMT2A
SCHEMBL3204346 0.86 PPARA (0.39) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL3211471 0.85 SLC7A5 (0.41) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL3195028 0.82 PDE4B (0.38) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL3263662 0.81 TAAR1 (0.43)
SCHEMBL3126329 0.81 SLC7A5 (0.35) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL4196553 0.81 GRM2 (0.40) PDE4APDE4DPDE4BPDE4CSLC7A5
SCHEMBL3129281 0.81 SLC7A5 (0.39) PDE4APDE4DPDE4BPDE4CSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B PDE4A 1/4885PDE4D 9/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.